Healthcare provider profile · identity verified

Jesus Gonzalez, MD

General Practice · BOCA RATON, FL · NPI 1336131671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	136
Levothyroxine Sodium	Levothyroxine Sodium	288	98
Losartan Potassium	Losartan Potassium	257	87
Amlodipine Besylate	Amlodipine Besylate	240	87
Rosuvastatin Calcium	Rosuvastatin Calcium	239	85
Metformin Hcl	Metformin Hcl	216	78
Lisinopril	Lisinopril	214	81
Alprazolam	Alprazolam	159	37
Hydrochlorothiazide	Hydrochlorothiazide	152	53
Fluticasone Propionate	Fluticasone Propionate	148	76
Simvastatin	Simvastatin	144	48
Omeprazole	Omeprazole	132	60
Meloxicam	Meloxicam	129	56
Metoprolol Succinate	Metoprolol Succinate	129	49
Pantoprazole Sodium	Pantoprazole Sodium	120	46
Diclofenac Sodium	Diclofenac Sodium	112	43
Gabapentin	Gabapentin	103	38
Famotidine	Famotidine	100	47
Tamsulosin Hcl	Tamsulosin Hcl	97	31
Metoprolol Tartrate	Metoprolol Tartrate	95	34
Albuterol Sulfate Hfa	Albuterol Sulfate	88	35
Temazepam	Temazepam	83	15
Doxycycline Hyclate	Doxycycline Hyclate	80	70
Alendronate Sodium	Alendronate Sodium	75	22
Tramadol Hcl	Tramadol Hcl	68	43
Zolpidem Tartrate	Zolpidem Tartrate	66	15
Ezetimibe	Ezetimibe	65	25
Glipizide	Glipizide	65	24
Montelukast Sodium	Montelukast Sodium	65	24
Amitriptyline Hcl	Amitriptyline Hcl	64	25
Finasteride	Finasteride	63	24
Sertraline Hcl	Sertraline Hcl	59	20
Eliquis	Apixaban	57	18
Clonazepam	Clonazepam	55	suppressed
Pravastatin Sodium	Pravastatin Sodium	55	17
Trulicity	Dulaglutide	55	11
Carvedilol	Carvedilol	53	17
Clopidogrel	Clopidogrel Bisulfate	53	21
Methylprednisolone	Methylprednisolone	49	41
Nifedipine Er	Nifedipine	49	13
Glipizide Er	Glipizide	45	12
Memantine Hcl	Memantine Hcl	45	19
Oxybutynin Chloride	Oxybutynin Chloride	45	12
Atenolol	Atenolol	44	13
Furosemide	Furosemide	44	16
Trazodone Hcl	Trazodone Hcl	44	16
Triamcinolone Acetonide	Triamcinolone Acetonide	43	22
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Donepezil Hcl	Donepezil Hcl	38	17
Hydroxyzine Hcl	Hydroxyzine Hcl	38	16
Naproxen	Naproxen	37	17
Lorazepam	Lorazepam	35	suppressed
Meclizine Hcl	Meclizine Hcl	35	25
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	suppressed
Potassium Chloride	Potassium Chloride	32	11
Valsartan	Valsartan	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	13
Lantus	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Cefuroxime	Cefuroxime Axetil	29	26
Clonidine Hcl	Clonidine Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	26
Propranolol Hcl	Propranolol Hcl	29	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	12
Lovastatin	Lovastatin	25	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Fluconazole	Fluconazole	21	11
Pregabalin	Pregabalin	21	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Betamethasone Valerate	Betamethasone Valerate	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	14
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Azithromycin	Azithromycin	17	16
Linzess	Linaclotide	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Diazepam	Diazepam	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Estradiol	Estradiol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Jardiance	Empagliflozin	13	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Ozempic	Semaglutide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Baclofen	Baclofen	11	suppressed
Ciclopirox	Ciclopirox	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error